Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10 » default
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (582)
- Volume 11, 2024 (58)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 10, 2023
- default (176)
- The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
- Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (5)
- Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (3)
Novel Preoperative Type IV Collagen to Predict the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Cirrhotic Portal Hypertension After Laparoscopic Splenectomy and Azygoportal Disconnection
Gao TM, Jin SJ, Fang F, Qian JJ, Zhang C, Zhou BH, Bai DS, Jiang GQ
Journal of Hepatocellular Carcinoma 2023, 10:2411-2420
Published Date: 12 January 2024
Pencil Beam Scanning Carbon Ion Radiotherapy for Hepatocellular Carcinoma
Zhang W, Cai X, Sun J, Wang W, Zhao J, Zhang Q, Jiang G, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:2397-2409
Published Date: 29 December 2023
Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis
Liu HT, Rau CS, Liu YW, Hsieh TM, Huang CY, Chien PC, Lin HP, Wu CJ, Chuang PC, Hsieh CH
Journal of Hepatocellular Carcinoma 2023, 10:2383-2395
Published Date: 28 December 2023
Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT
Liu B, Liu J, Mei X, Zhang ZQ, Fang J, Zhou LL, Zheng JL, Lin HY, Zhu XL, Li DL
Journal of Hepatocellular Carcinoma 2023, 10:2367-2382
Published Date: 28 December 2023
Surgical Strategies Affect the Long-Term Prognosis of Patients with Hepatocellular Carcinoma Adjacent to the Left Branch of the Portal Vein
Bai S, Shen X, Liu J, Lu C, Wang J, Liu L, Wang C, Wang H, Liu K, Sun Y, Xue F
Journal of Hepatocellular Carcinoma 2023, 10:2355-2366
Published Date: 27 December 2023
Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma
Chen H, Cao D, Han N, Zhang M, Jiang W, Wang X, Zeng Q, Tang H
Journal of Hepatocellular Carcinoma 2023, 10:2337-2353
Published Date: 27 December 2023
Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients
Wang X, Yu Y, Tao Y, Wang Y, Zhang C, Cui Y, Zhou Y
Journal of Hepatocellular Carcinoma 2023, 10:2323-2335
Published Date: 21 December 2023
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
Peng Y, Wu X, Zhang Y, Yin Y, Chen X, Zheng D, Wang J
Journal of Hepatocellular Carcinoma 2023, 10:2305-2321
Published Date: 18 December 2023
Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics
Wang Y, Weng W, Liang R, Zhou Q, Hu H, Li M, Chen L, Chen S, Peng S, Kuang M, Xiao H, Wang W
Journal of Hepatocellular Carcinoma 2023, 10:2291-2303
Published Date: 18 December 2023
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Hoang TPT, Schindler P, Börner N, Masthoff M, Gerwing M, von Beauvais P, De Toni EN, Lange CM, Trebicka J, Morgül H, Seidensticker M, Ricke J, Pascher A, Guba M, Ingrisch M, Wildgruber M, Öcal O
Journal of Hepatocellular Carcinoma 2023, 10:2277-2289
Published Date: 18 December 2023
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B
Journal of Hepatocellular Carcinoma 2023, 10:2265-2276
Published Date: 13 December 2023
Survival Prediction Model for Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis Based on XGBoost Algorithm
Lim J, Jeon HG, Seo Y, Kim M, Moon JU, Cho SH
Journal of Hepatocellular Carcinoma 2023, 10:2251-2263
Published Date: 13 December 2023
Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin
Xu L, Zhao D, Tian P, Ding J, Jiang Z, Ni G, Hou Z, Ni C
Journal of Hepatocellular Carcinoma 2023, 10:2239-2250
Published Date: 13 December 2023
Nomogram for Estimation of Acute Liver Failure Risk in Spontaneous Ruptured Hepatocellular Carcinoma
Zhao ZH, Jiang C, Wu QY, Lv GY, Wang M
Journal of Hepatocellular Carcinoma 2023, 10:2223-2237
Published Date: 12 December 2023
The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization
Tang HH, Zhang MQ, Zhang ZC, Fan C, Jin Y, Wang WD
Journal of Hepatocellular Carcinoma 2023, 10:2211-2221
Published Date: 12 December 2023
Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma
Xu Y, Li Y, Lu Y, Wang W, Lian Z, Wu Z, Li B, Yu D
Journal of Hepatocellular Carcinoma 2023, 10:2197-2209
Published Date: 7 December 2023
Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus
Zhang L, Wang J, Li Y, Hou L, Xia J, Shen J
Journal of Hepatocellular Carcinoma 2023, 10:2187-2196
Published Date: 6 December 2023
miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway
Xing K, Bian X, Shi D, Dong S, Zhou H, Xiao S, Bai J, Wu W
Journal of Hepatocellular Carcinoma 2023, 10:2173-2185
Published Date: 6 December 2023
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Wu JY, Wu JY, Liu DY, Li H, Zhuang SW, Li B, Zhou JY, Huang JY, Zhang ZB, Li SQ, Yan ML, Wang YD
Journal of Hepatocellular Carcinoma 2023, 10:2161-2171
Published Date: 5 December 2023
The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma [Corrigendum]
Zhang Y, Sheng R, Yang C, Dai Y, Zeng M
Journal of Hepatocellular Carcinoma 2023, 10:2159-2160
Published Date: 2 December 2023
Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003–2021
Tran S, Zou B, Kam L, Lee K, Huang DQ, Henry L, Cheung R, Nguyen MH
Journal of Hepatocellular Carcinoma 2023, 10:2147-2158
Published Date: 2 December 2023
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy
Wu T, Zheng Z, Wang J, He M, Wang J, Pan Y, Chen J, Hu D, Zhang Y, Xu L, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2023, 10:2133-2145
Published Date: 1 December 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2023, 10:2117-2132
Published Date: 30 November 2023
Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation
Liu HF, Lu Y, Wang Q, Lu YJ, Xing W
Journal of Hepatocellular Carcinoma 2023, 10:2103-2115
Published Date: 29 November 2023
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]
Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno AF, El Dorry A, Hosni A, Helmy A, Saad AS, Alolayan A, Eysa BE, Hamada E, Azim H, Khattab H, Elghazaly H, Tawfik H, Ayoub H, Khaled H, Saadeldin I, Waked I, Barakat EMF, El Meteini M, Hamed Shaaban M, EzzElarab M, Fathy M, Shaker M, Sobhi M, Shaker MK, ElGharib M, Abdullah M, Mokhtar M, Elshazli M, Heikal OMK, Hetta O, ElWakil RM, Abdel Wahab S, Eid SS, Rostom Y
Journal of Hepatocellular Carcinoma 2023, 10:2101-2102
Published Date: 24 November 2023
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
Li Z, Zhang Z, Fang L, Zhao J, Niu Z, Chen H, Cao G
Journal of Hepatocellular Carcinoma 2023, 10:2083-2099
Published Date: 21 November 2023
Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy
Hu ZX, Xu XY, Wang Z, Huang JT, Li WC, Zhang S, Shen J, Zhong BY, Zhu XL
Journal of Hepatocellular Carcinoma 2023, 10:2073-2082
Published Date: 21 November 2023
Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection
Li HM, Huang W, Hu C, Zhang ZS, Xiao YD, Wang TC
Journal of Hepatocellular Carcinoma 2023, 10:2059-2071
Published Date: 20 November 2023
Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab
Xiao Y, Zhu G, Xie J, Luo L, Deng W, Lin L, Tao J, Hu Z, Shan R
Journal of Hepatocellular Carcinoma 2023, 10:2049-2058
Published Date: 9 November 2023
Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre
Li G, Zhao Y, Li K, Yang S, Xiang C, Song J, Yang Y, Li G, Dong J
Journal of Hepatocellular Carcinoma 2023, 10:2037-2048
Published Date: 9 November 2023
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway
Gao Y, Li Y, Liu Z, Dong Y, Yang S, Wu B, Xiao M, Chen C, Wen Y, Chen L, Jiang H, Yao Y
Journal of Hepatocellular Carcinoma 2023, 10:2021-2036
Published Date: 8 November 2023
Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma
Qin Q, Kou X, Zheng Y, Zhou F, Zhang X, Liu H
Journal of Hepatocellular Carcinoma 2023, 10:2009-2019
Published Date: 6 November 2023
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
Wei H, Huang L, Lu Q, Huang Z, Huang Y, Xu Z, Li W, Pu J
Journal of Hepatocellular Carcinoma 2023, 10:1991-2007
Published Date: 6 November 2023
Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma
Mauda-Havakuk M, Hawken NM, Owen JW, Mikhail AS, Starost MF, Karim B, Wakim PG, Franco-Mahecha OL, Lewis AL, Pritchard WF, Karanian JW, Wood BJ
Journal of Hepatocellular Carcinoma 2023, 10:1973-1990
Published Date: 6 November 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
Manfredi GF, Celsa C, John C, Jones C, Acuti N, Scheiner B, Fulgenzi CAM, Korolewicz J, Pinter M, Gennari A, Mauri FA, Pirisi M, Minisini R, Vincenzi F, Burlone M, Rigamonti C, Donadon M, Cabibbo G, D'Alessio A, Pinato DJ
Journal of Hepatocellular Carcinoma 2023, 10:1955-1971
Published Date: 3 November 2023
A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis
Koksal AR, Ekmen N, Aydin Y, Nunez K, Sandow T, Delk M, Moehlen M, Thevenot P, Cohen A, Dash S
Journal of Hepatocellular Carcinoma 2023, 10:1935-1954
Published Date: 2 November 2023
Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
Da Fonseca LG, Yamamoto VJ, Trinconi Cunha M, Torre GS, Araujo RL, Fonseca GM, Chen ATC, Chagas AL, Herman P, Alves VAF, Carrilho FJ
Journal of Hepatocellular Carcinoma 2023, 10:1923-1933
Published Date: 1 November 2023
Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
Ahmed Z, Lee SS, Victor DW 3rd, Kodali S
Journal of Hepatocellular Carcinoma 2023, 10:1911-1922
Published Date: 27 October 2023
Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
Yang Y, Du N, Ma J, Peng Z, Zhou B, Yu J, Zhou X, Zhang W, Yan Z
Journal of Hepatocellular Carcinoma 2023, 10:1897-1910
Published Date: 25 October 2023
Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization
Tu X, Zhang J, Li M, Lu F, Wang T, Gong W, Xiang B
Journal of Hepatocellular Carcinoma 2023, 10:1881-1895
Published Date: 24 October 2023
The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Hsu HM, Tsai HI, Lee WC, Wang CC, Yu MC, Lin SM, Lin CY, Wu CH, Lee CW
Journal of Hepatocellular Carcinoma 2023, 10:1873-1880
Published Date: 24 October 2023
Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization
Shi Q, Huang P, Zhang Z, Zhang W, Liu L, Yan Z
Journal of Hepatocellular Carcinoma 2023, 10:1861-1871
Published Date: 21 October 2023
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Long T, Yang Z, Zeng H, Wu W, Hu Z, Yang Z, Hu D, Zhou Z, Chen M, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:1849-1859
Published Date: 20 October 2023
Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3–7 Cm
Yang J, Liang S, Liu H, Hu C, Guan S, Kang H, Xu E, Yan R
Journal of Hepatocellular Carcinoma 2023, 10:1839-1848
Published Date: 18 October 2023
Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
Luo MC, Wu JY, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML
Journal of Hepatocellular Carcinoma 2023, 10:1827-1837
Published Date: 12 October 2023
Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Lin Q, Jiang Z, Mo D, Liu F, Qin Y, Liang Y, Cheng Y, Huang H, Fang M
Journal of Hepatocellular Carcinoma 2023, 10:1813-1825
Published Date: 11 October 2023
Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
Li SQ, Wu JY, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML
Journal of Hepatocellular Carcinoma 2023, 10:1799-1811
Published Date: 11 October 2023
Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma
Chen S, Duan Y, Zhang Y, Cheng L, Cai L, Hou X, Li W
Journal of Hepatocellular Carcinoma 2023, 10:1785-1797
Published Date: 10 October 2023
Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment
Zhi R, Hao P, Li W, Zhao H
Journal of Hepatocellular Carcinoma 2023, 10:1767-1784
Published Date: 9 October 2023
Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma
Lin SS, Cao Y, Zhu K, Yang CN, Zhu XP, Zhang HH, Zhang R
Journal of Hepatocellular Carcinoma 2023, 10:1749-1765
Published Date: 9 October 2023
Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L
Journal of Hepatocellular Carcinoma 2023, 10:1735-1748
Published Date: 6 October 2023
Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
Yan J, Wen Y, Deng M, Ye B, Liu X, Zhang L
Journal of Hepatocellular Carcinoma 2023, 10:1723-1733
Published Date: 5 October 2023
Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma
Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L
Journal of Hepatocellular Carcinoma 2023, 10:1709-1721
Published Date: 4 October 2023
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
Zanuso V, Pirozzi A, Balsano R, Pressiani T, Rimassa L
Journal of Hepatocellular Carcinoma 2023, 10:1689-1708
Published Date: 2 October 2023
Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma
Xiao J, Wang J, Zhou C, Luo J
Journal of Hepatocellular Carcinoma 2023, 10:1673-1687
Published Date: 2 October 2023
The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma
Zhang Y, Sheng R, Yang C, Dai Y, Zeng M
Journal of Hepatocellular Carcinoma 2023, 10:1659-1671
Published Date: 29 September 2023
A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma
Huang Y, Xu J, Xie C, Liao Y, Lin R, Zeng Y, Yu F
Journal of Hepatocellular Carcinoma 2023, 10:1639-1657
Published Date: 28 September 2023
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
Jiang JQ, Huang JT, Zhong BY, Wang WD, Sun JH, Wang Q, Ding WB, Ni CF, Zhu XL
Journal of Hepatocellular Carcinoma 2023, 10:1629-1638
Published Date: 26 September 2023
Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma
Gong J, Yu R, Hu X, Luo H, Gao Q, Li Y, Tan G, Luo H, Qin B
Journal of Hepatocellular Carcinoma 2023, 10:1609-1628
Published Date: 25 September 2023
MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity
Chen Z, Li X, Zhang Y, Yang Y, Zhang Y, Zhou D, Yang Y, Zhang S, Liu Y
Journal of Hepatocellular Carcinoma 2023, 10:1595-1608
Published Date: 25 September 2023
Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports
Tian Y, Jin W, Sun H, Jin D, Kang D, Li Z, Piao L
Journal of Hepatocellular Carcinoma 2023, 10:1587-1593
Published Date: 25 September 2023
Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma – A Nationwide Swedish Register-Based Study
Thörn R, Hemmingsson O, Danielsson Borssén Å, Werner M, Karling P, Wixner J
Journal of Hepatocellular Carcinoma 2023, 10:1573-1586
Published Date: 19 September 2023
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno AF, El Dorry A, Hosni A, Helmy A, Saad AS, Alolayan A, Eysa BE, Hamada E, Azim H, Khattab H, Elghazaly H, Tawfik H, Ayoub H, Khaled H, Saadeldin I, Waked I, Barakat EMF, El Meteini M, Hamed Shaaban M, EzzElarab M, Fathy M, Shaker M, Sobhi M, Shaker MK, ElGharib M, Abdullah M, Mokhtar M, Elshazli M, Heikal OMK, Hetta O, ElWakil RM, Abdel Wahab S, Eid SS, Rostom Y
Journal of Hepatocellular Carcinoma 2023, 10:1547-1571
Published Date: 18 September 2023
Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies
El Sayed SM
Journal of Hepatocellular Carcinoma 2023, 10:1527-1546
Published Date: 13 September 2023
Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium
Ning S, Li X, Ma X, Liu J, Chang X
Journal of Hepatocellular Carcinoma 2023, 10:1511-1525
Published Date: 13 September 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J
Journal of Hepatocellular Carcinoma 2023, 10:1497-1509
Published Date: 6 September 2023
N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC
Tan C, Huang Y, Huang Z, Ning Y, Huang L, Wu X, Lu Y, Wei H, Pu J
Journal of Hepatocellular Carcinoma 2023, 10:1479-1495
Published Date: 6 September 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J
Journal of Hepatocellular Carcinoma 2023, 10:1465-1477
Published Date: 6 September 2023
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
Carloni R, Sabbioni S, Rizzo A, Ricci AD, Palloni A, Petrarota C, Cusmai A, Tavolari S, Gadaleta-Caldarola G, Brandi G
Journal of Hepatocellular Carcinoma 2023, 10:1445-1463
Published Date: 6 September 2023
Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study
Yang H, Yang T, Qiu G, Liu J
Journal of Hepatocellular Carcinoma 2023, 10:1435-1443
Published Date: 5 September 2023
Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
Xie YM, Lu W, Cheng J, Dai M, Liu SY, Wang DD, Fu TW, Ye TW, Liu JW, Zhang CW, Huang DS, Liang L
Journal of Hepatocellular Carcinoma 2023, 10:1423-1433
Published Date: 4 September 2023
Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma
Pei Y, Zhang Z, Tan S
Journal of Hepatocellular Carcinoma 2023, 10:1411-1422
Published Date: 25 August 2023
A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients
Zhou Z, Cao S, Chen C, Chen J, Xu X, Liu Y, Liu Q, Wang K, Han B, Yin Y
Journal of Hepatocellular Carcinoma 2023, 10:1399-1409
Published Date: 23 August 2023
Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review
Wang X, Zhao M, Zhang C, Chen H, Liu X, An Y, Zhang L, Guo X
Journal of Hepatocellular Carcinoma 2023, 10:1389-1398
Published Date: 22 August 2023
Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial
Guo J, Bao X, Liu F, Guo J, Wu Y, Xiong F, Lu J
Journal of Hepatocellular Carcinoma 2023, 10:1379-1388
Published Date: 21 August 2023
Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis
Kong Q, Yi M, Teng F, Li H, Chen Z
Journal of Hepatocellular Carcinoma 2023, 10:1367-1377
Published Date: 16 August 2023
Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China
Ke Q, Guo Z, He J, Lai Z, Xin F, Zeng Y, Wang L, Liu J
Journal of Hepatocellular Carcinoma 2023, 10:1353-1365
Published Date: 16 August 2023
Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
Gong B, Wang X, Guo W, Yang H, Shi Y, Chen Y, Gao S, Chen J, Liu L, Lu L, Chen X
Journal of Hepatocellular Carcinoma 2023, 10:1341-1351
Published Date: 11 August 2023
Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive Microenvironment
Wu D, Liao G, Yao Y, Huang L, Dong B, Ma Y, Yang G
Journal of Hepatocellular Carcinoma 2023, 10:1327-1339
Published Date: 9 August 2023
Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma
He L, Xie Y, Qiu Y, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:1309-1325
Published Date: 9 August 2023
Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
Chen C, Liu J, Gu Z, Sun Y, Lu W, Liu X, Chen K, Ma T, Zhao S, Zhao H
Journal of Hepatocellular Carcinoma 2023, 10:1295-1308
Published Date: 8 August 2023
TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling
Lu X, Yuan Y, Cai N, Rao D, Chen M, Chen X, Zhang B, Liang H, Zhang L
Journal of Hepatocellular Carcinoma 2023, 10:1281-1293
Published Date: 3 August 2023
T-Lymphocyte Gene-Regulated CCL5 and Its Association with Extrahepatic Metastasis in Hepatocellular Carcinoma
Dong G, Fan F, He Y, Luo Y, Yu J, Liang P
Journal of Hepatocellular Carcinoma 2023, 10:1267-1279
Published Date: 2 August 2023
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis
Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y
Journal of Hepatocellular Carcinoma 2023, 10:1257-1266
Published Date: 29 July 2023
A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway
Sun J, Li Y, Shi M, Tian H, Li J, Zhu K, Guo Y, Mu Y, Geng J, Li Z
Journal of Hepatocellular Carcinoma 2023, 10:1237-1256
Published Date: 27 July 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States
Monge C, Maldonado JA, McGlynn KA, Greten TF
Journal of Hepatocellular Carcinoma 2023, 10:1223-1235
Published Date: 27 July 2023
Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study
Chen S, Shi F, Wu Z, Wang L, Cai H, Ma P, Zhou Y, Mai Q, Wang F, Tang S, Zhuang W, Lai J, Chen X, Chen H, Guo W
Journal of Hepatocellular Carcinoma 2023, 10:1209-1222
Published Date: 27 July 2023
Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses [Corrigendum]
Huang CY, Lai ZY, Hsu TJ, Chou FI, Liu HM, Chuang YJ
Journal of Hepatocellular Carcinoma 2023, 10:1207-1208
Published Date: 26 July 2023
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
Zhao C, Xiang Z, Li M, Wang H, Liu H, Yan H, Huang M
Journal of Hepatocellular Carcinoma 2023, 10:1195-1206
Published Date: 25 July 2023
Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma
Sun X, Wang Y, Ge H, Chen C, Han X, Sun K, Wang M, Wei X, Ye M, Zhang Q, Liang T
Journal of Hepatocellular Carcinoma 2023, 10:1181-1194
Published Date: 25 July 2023
The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1
Yao Z, Liu N, Lin H, Zhou Y
Journal of Hepatocellular Carcinoma 2023, 10:1169-1180
Published Date: 21 July 2023
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma
Yang Z, Hu Z, Fu Y, Hu D, Zhou Z, Chen M, Pan Y, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:1157-1167
Published Date: 21 July 2023
Estimating Microvascular Invasion in Patients with Resectable Multinodular Hepatocellular Carcinoma by Using Preoperative Contrast-Enhanced MRI: Establishment and Validation of a Risk Score
Wu F, Sun H, Shi Z, Zhou C, Huang P, Xiao Y, Yang C, Zeng M
Journal of Hepatocellular Carcinoma 2023, 10:1143-1156
Published Date: 20 July 2023
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
Ozer M, Goksu SY, Lin RY, Ayasun R, Kahramangil D, Rogers SC, Fabregas JC, Ramnaraign BH, George TJ, Feely M, Cabrera R, Duarte S, Zarrinpar A, Sahin I
Journal of Hepatocellular Carcinoma 2023, 10:1129-1141
Published Date: 19 July 2023
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
Yu J, Park R, Kim R
Journal of Hepatocellular Carcinoma 2023, 10:1105-1127
Published Date: 18 July 2023
The Long Non-Coding RNA AC006329.1 Facilitates Hepatocellular Carcinoma Progression and Metastasis by Regulating miR-127-5p/SHC3/ERK Axis
Kong XX, Yang X, Jiang WJ, Zhu DM, Kong LB
Journal of Hepatocellular Carcinoma 2023, 10:1085-1103
Published Date: 17 July 2023
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Tao M, Han J, Shi J, Liao H, Wen K, Wang W, Mui S, Li H, Yan Y, Xiao Z
Journal of Hepatocellular Carcinoma 2023, 10:1069-1083
Published Date: 10 July 2023
Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes
Zhang Y, Cui K, Yang Y, Liu B, Zhu M, Chen H, Zhao C, Zhou Y, Nie Y
Journal of Hepatocellular Carcinoma 2023, 10:1051-1067
Published Date: 8 July 2023
The Predictive Role of Inflammatory Biomarkers for Treatment Response and Progression-Free Survival in Patients with Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy with FOLFOX Regimen: A Preliminary Study
Zhao Y, Liu J, Xiong Z, Gu S, Xia X
Journal of Hepatocellular Carcinoma 2023, 10:1037-1049
Published Date: 8 July 2023
LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
Wei Q, Liu G, Huang Z, Huang Y, Huang L, Huang Z, Wu X, Wei H, Pu J
Journal of Hepatocellular Carcinoma 2023, 10:1019-1035
Published Date: 5 July 2023
Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study
Li H, Guo L, Su K, Li C, Jiang Y, Wang P, Chen J, Wu Z, Xu K, Gu T, Zeng H, He K, Chi H, Zhao W, Han L, Han Y
Journal of Hepatocellular Carcinoma 2023, 10:1009-1017
Published Date: 29 June 2023
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe
Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y
Journal of Hepatocellular Carcinoma 2023, 10:997-1007
Published Date: 28 June 2023
Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis
De la Garza-Ramos C, Montazeri SA, Musto KR, Kapp MD, Lewis AR, Frey G, Paz-Fumagalli R, Ilyas S, Harnois DM, Majeed U, Patel T, Toskich B
Journal of Hepatocellular Carcinoma 2023, 10:987-996
Published Date: 23 June 2023
Comparison of Ablation Volume Between Emprint® and Mimapro® Systems for Hepatocellular Carcinoma –A Preliminary Study
Ishikawa T, Hasegawa I, Hirosawa H, Honmou T, Sakai N, Igarashi T, Yamazaki S, Kobayashi T, Sato T, Iwanaga A, Sano T, Yokoyama J, Honma T
Journal of Hepatocellular Carcinoma 2023, 10:979-985
Published Date: 22 June 2023
An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)
Huang P, Hu YD, Liu YJ, Li JP, Zhang YH
Journal of Hepatocellular Carcinoma 2023, 10:959-978
Published Date: 22 June 2023
Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China
Li J, Huang L, Ge C, Zhu X, Qiu M, Chen C, Wei S, Yan Y
Journal of Hepatocellular Carcinoma 2023, 10:949-958
Published Date: 20 June 2023
Phellodendronoside A Exerts Anticancer Effects Depending on Inducing Apoptosis Through ROS/Nrf2/Notch Pathway and Modulating Metabolite Profiles in Hepatocellular Carcinoma
Si Y, Hui C, Guo T, Liu M, Chen X, Dong C, Feng S
Journal of Hepatocellular Carcinoma 2023, 10:935-948
Published Date: 20 June 2023
PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
Asghar K, Bashir S, Ali Rana I, Abu Bakar M, Farooq A, Hassan M, Asif Z, Afzal M, Masood I, Ishaq M, Tahseen M, Bilal S, Mehmood S, Kanwal N, Ud Din I, Loya A
Journal of Hepatocellular Carcinoma 2023, 10:921-934
Published Date: 17 June 2023
Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization
Xi D, Xu M, Han M, Guan Q, Guo Q, Yan F, Yao J, Ning Q
Journal of Hepatocellular Carcinoma 2023, 10:909-920
Published Date: 16 June 2023
Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese Medicine
Liu S, Kang L, Song Y, Miao M
Journal of Hepatocellular Carcinoma 2023, 10:893-908
Published Date: 8 June 2023
Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
Pan X, Wu SJ, Tang Y, Zhou YF, Luo JW, Fang ZT
Journal of Hepatocellular Carcinoma 2023, 10:883-892
Published Date: 9 June 2023
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p
Li L, Ai R, Yuan X, Dong S, Zhao D, Sun X, Miao T, Guan W, Guo P, Yu S, Nan Y
Journal of Hepatocellular Carcinoma 2023, 10:863-881
Published Date: 8 June 2023
Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus
Chang X, Yu S, Pang J, Zhang W, Kong H, Huang J, Zhang G, Zhang H, Gu Y, Chen Y, Yang B, Liu J, Zeng Z
Journal of Hepatocellular Carcinoma 2023, 10:847-861
Published Date: 6 June 2023
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
Sun L, Zhao H, Ding XY, Yang K, Wang GS, Chen JM, Han XY, Wan G, Zhang L, Zhou XG, Chen XM, Wang P, Xie W
Journal of Hepatocellular Carcinoma 2023, 10:833-846
Published Date: 5 June 2023
Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma
Zhou J, Yang D
Journal of Hepatocellular Carcinoma 2023, 10:821-831
Published Date: 2 June 2023
Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
Wu SJ, Ruan DD, Wu QY, Tang Y, Zhang JH, Cai SL, Zhou YF, Luo JW, Fang ZT
Journal of Hepatocellular Carcinoma 2023, 10:807-820
Published Date: 2 June 2023
Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study
Guo L, Li X, Zhang C, Xu Y, Han L, Zhang L
Journal of Hepatocellular Carcinoma 2023, 10:795-806
Published Date: 2 June 2023
Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
Do XH, Le MT, Nguyen TH, Le TT, Nguyen XH, Mai TB, Hoang TMN, Than UTT
Journal of Hepatocellular Carcinoma 2023, 10:783-793
Published Date: 26 May 2023
Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma
Tang Y, Cao J, Peng R, Mao X, Su B, Tang H, Tu D, Zhou J, Jiang G, Jin S, Wang Q, Zhang C, Liu R, Zhang C, Bai D
Journal of Hepatocellular Carcinoma 2023, 10:765-781
Published Date: 22 May 2023
Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
Tao C, Wu F, Wang H, Wang L, Liu Y, Wu A, Zheng L, Wang Y, Chen B, Rong W, Wu J
Journal of Hepatocellular Carcinoma 2023, 10:753-764
Published Date: 16 May 2023
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
Gummadi J, Wang X, Xie C
Journal of Hepatocellular Carcinoma 2023, 10:745-752
Published Date: 15 May 2023
Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma
Dong TT, Wang L, Li M, Yin C, Li YY, Nie F
Journal of Hepatocellular Carcinoma 2023, 10:733-743
Published Date: 15 May 2023
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance
Scott RA, Cross TJS, Clarke C, Khan SA, Ryder SD, Franklin J, Aravinthan AD
Journal of Hepatocellular Carcinoma 2023, 10:725-731
Published Date: 29 April 2023
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Costante F, Stella L, Santopaolo F, Gasbarrini A, Pompili M, Asselah T, Ponziani FR
Journal of Hepatocellular Carcinoma 2023, 10:713-724
Published Date: 25 April 2023
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma
Zhou C, Yang ZF, Sun BY, Yi Y, Wang Z, Zhou J, Fan J, Gan W, Ren N, Qiu SJ
Journal of Hepatocellular Carcinoma 2023, 10:697-712
Published Date: 24 April 2023
Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study
Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X
Journal of Hepatocellular Carcinoma 2023, 10:687-695
Published Date: 21 April 2023
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
Gan L, Lang M, Tian X, Ren S, Li G, Liu Y, Han R, Zhu K, Li H, Wu Q, Cui Y, Zhang W, Fang F, Li Q, Song T
Journal of Hepatocellular Carcinoma 2023, 10:673-686
Published Date: 22 April 2023
A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients
Wang S, Zhang X, Chen Q, Jin ZC, Lu J, Guo J
Journal of Hepatocellular Carcinoma 2023, 10:659-671
Published Date: 20 April 2023
Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
Ju MH, Jang EJ, Kang SH, Roh YH, Jeong JS, Han SH
Journal of Hepatocellular Carcinoma 2023, 10:643-658
Published Date: 20 April 2023
Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-Up
Luo L, Yan R, Zeng Q, Long Y, He X, Li K, Xu E
Journal of Hepatocellular Carcinoma 2023, 10:631-642
Published Date: 13 April 2023
Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro
Xiu Z, Li Y, Fang J, Han J, Li S, Li Y, Yang X, Song G, Li Y, Jin N, Zhu Y, Zhu G, Sun L, Li X
Journal of Hepatocellular Carcinoma 2023, 10:611-629
Published Date: 11 April 2023
Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Zhang X, Gu C, Wei Q, Cao Y, She W, Shi H, Xie Y, Guo J
Journal of Hepatocellular Carcinoma 2023, 10:599-609
Published Date: 11 April 2023
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
Wang X, Yang X, Wang J, Dong C, Ding J, Wu M, Wang Y, Ding H, Zhang H, Sang X, Zhao H, Huo L
Journal of Hepatocellular Carcinoma 2023, 10:587-598
Published Date: 8 April 2023
Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
Huang J, Li L, Liu FC, Tan BB, Yang Y, Jiang BG, Pan ZY
Journal of Hepatocellular Carcinoma 2023, 10:573-586
Published Date: 6 April 2023
Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma
Zhang X, Zhang C, Zhao Q, Wang S, Wang L, Si Y, Su Q, Cheng S, Ding W
Journal of Hepatocellular Carcinoma 2023, 10:553-571
Published Date: 5 April 2023
Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma
Dai T, Li J, Liang RB, Yu H, Lu X, Wang G
Journal of Hepatocellular Carcinoma 2023, 10:531-551
Published Date: 3 April 2023
High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth
Cao Z, Guan L, Yu R, Yang F, Chen J
Journal of Hepatocellular Carcinoma 2023, 10:517-530
Published Date: 1 April 2023
An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)
Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:497-515
Published Date: 30 March 2023
Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models
Wang M, Yao X, Bo Z, Zheng J, Yu H, Xie X, Lin Z, Wang Y, Chen G, Wu L
Journal of Hepatocellular Carcinoma 2023, 10:483-495
Published Date: 27 March 2023
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
Benevento F, Pecorelli A, Stefanescu H, Sparchez Z, Vukotic R, Pettinari I, Grigoras CA, Tovoli F, Ravaioli F, Stefanini B, Andreone P, Piscaglia F
Journal of Hepatocellular Carcinoma 2023, 10:473-482
Published Date: 27 March 2023
Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
Xu J, Zhang K, Zhang G
Journal of Hepatocellular Carcinoma 2023, 10:459-472
Published Date: 21 March 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC
Sun T, Ren Y, Sun B, Chen L, Zhu L, Zhang L, Zheng C
Journal of Hepatocellular Carcinoma 2023, 10:447-457
Published Date: 16 March 2023
LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin
Chen Y, Wu X, Chen X, Guo D, Ma W, Guo Y, Xu K, Ma S, Yuan Y, Zhu Q
Journal of Hepatocellular Carcinoma 2023, 10:429-446
Published Date: 14 March 2023
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
Ito T, Nguyen MH
Journal of Hepatocellular Carcinoma 2023, 10:413-428
Published Date: 10 March 2023
Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
Li Y, Ni X, Liu X, Yang C, Wang Y, Lu X, Zhou C
Journal of Hepatocellular Carcinoma 2023, 10:399-411
Published Date: 9 March 2023
Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma
Lin C, He Y, Liu M, Wu A, Zhang J, Li S, Li S, Cao Q, Liu F
Journal of Hepatocellular Carcinoma 2023, 10:383-397
Published Date: 7 March 2023
Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma
Huang ZL, Zhang PB, Zhang JT, Li F, Li TT, Huang XY
Journal of Hepatocellular Carcinoma 2023, 10:369-382
Published Date: 7 March 2023
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma
Lei J, Yang S, Chen B, Zhang L, Yan T, Yang G, Chen Y, Li Y, Lu Y, Zuo S
Journal of Hepatocellular Carcinoma 2023, 10:357-367
Published Date: 2 March 2023
Pathogenesis of NAFLD-Related Hepatocellular Carcinoma: An Up-to-Date Review
Gao Y, Zhu R, Dong J, Li Z
Journal of Hepatocellular Carcinoma 2023, 10:347-356
Published Date: 1 March 2023
Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model
Shen H, Gu X, Li H, Tang M, Li X, Zhang Y, Su F, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:327-345
Published Date: 27 February 2023
ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy
Duan T, Yang X, Kuang J, Sun W, Li J, Ge J, Zhang M, Cai X, Yu P, Yang J, Zhu X
Journal of Hepatocellular Carcinoma 2023, 10:315-325
Published Date: 27 February 2023
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Yang X, Deng H, Sun Y, Zhang Y, Lu Y, Xu G, Huang X
Journal of Hepatocellular Carcinoma 2023, 10:303-313
Published Date: 27 February 2023
PET Imaging of Hepatocellular Carcinoma Using ZD2-(68Ga-NOTA)
Sergeeva O, Zhang Y, Gao S, Chan ER, Sergeev M, Iyer R, Sexton S, Avril N, Lu ZR, Lee Z
Journal of Hepatocellular Carcinoma 2023, 10:291-301
Published Date: 22 February 2023
Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
Chan KM, Lai Y, Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Wang CT, Chai PM, Lien HY, Lee WC
Journal of Hepatocellular Carcinoma 2023, 10:281-290
Published Date: 18 February 2023
Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
Zou X, Xu Q, You R, Yin G
Journal of Hepatocellular Carcinoma 2023, 10:267-279
Published Date: 16 February 2023
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
Jiang Z, Dai C
Journal of Hepatocellular Carcinoma 2023, 10:257-266
Published Date: 15 February 2023
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
Zhang Y, Liu Z, Li J, Li X, Duo M, Weng S, Lv P, Jiang G, Wang C, Li Y, Liu S, Li Z
Journal of Hepatocellular Carcinoma 2023, 10:241-255
Published Date: 15 February 2023
Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
Zhao XH, Li HL, Guo CY, Yao QJ, Xia WL, Hu HT
Journal of Hepatocellular Carcinoma 2023, 10:231-240
Published Date: 14 February 2023
Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy
Ma C, Cao Y, Zhang G, Qiu J, Zhou Y, Wang P, Wang S, Yan D, Ma D, Jiang C, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:217-230
Published Date: 9 February 2023
Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway
Tang S, Xu B, Pang H, Xiao L, Mei Q, He X
Journal of Hepatocellular Carcinoma 2023, 10:203-215
Published Date: 10 February 2023
Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection
Wu Q, Zeng J, Zeng J
Journal of Hepatocellular Carcinoma 2023, 10:193-202
Published Date: 8 February 2023
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
Laschtowitz A, Roderburg C, Tacke F, Mohr R
Journal of Hepatocellular Carcinoma 2023, 10:181-191
Published Date: 8 February 2023
Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
Huang P, Ni X, Zhou C, Shi Z, Wu F, Xiao Y, Yang C, Zeng M
Journal of Hepatocellular Carcinoma 2023, 10:169-180
Published Date: 8 February 2023
Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Using Contrast-Enhanced Ultrasound-Based Deep-Learning Radiomics Model
Qin X, Hu X, Xiao W, Zhu C, Ma Q, Zhang C
Journal of Hepatocellular Carcinoma 2023, 10:157-168
Published Date: 8 February 2023
Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma
He K, Liu X, Yang Z
Journal of Hepatocellular Carcinoma 2023, 10:139-156
Published Date: 5 February 2023
Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma
Li CJ, Tsai HW, Chen YL, Wang CI, Lin YH, Chu PM, Chi HC, Huang YC, Chen CY
Journal of Hepatocellular Carcinoma 2023, 10:123-138
Published Date: 30 January 2023
Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma
Yang X, Chang J, Li R, Qi Y, Zeng X, Wang W, Li H
Journal of Hepatocellular Carcinoma 2023, 10:113-122
Published Date: 26 January 2023
Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007–2019: A Retrospective Monocentric Cohort Study
Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy N, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M
Journal of Hepatocellular Carcinoma 2023, 10:99-111
Published Date: 25 January 2023
Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
Gama H, Albuquerque R, Campos Wanderley D, Pascoal Xavier MA, Osório FMF, Couto CA, Ferrari TCA, Lima AS, Diniz PHC, Vidigal PVT
Journal of Hepatocellular Carcinoma 2023, 10:91-98
Published Date: 22 January 2023
Efficacy and Safety of Combined Ethanol-Lipiodol Mixture and Drug-Eluting Bead TACE for Large HCC
Chuang YH, Cheng YF, Tsang LLC, Ou HY, Hsu HW, Lim WX, Huang PH, Weng CC, Yu CY
Journal of Hepatocellular Carcinoma 2023, 10:81-90
Published Date: 15 January 2023
Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Su K, Huang W, Li X, Xu K, Gu T, Liu Y, Song J, Qian K, Xu Y, Zeng H, Yang Y, Guo L, Han Y
Journal of Hepatocellular Carcinoma 2023, 10:69-79
Published Date: 14 January 2023
High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
Lu Z, Huang Y, Huang J, Ni HH, Luo T, Wei X, Bai X, Qi L, Xiang B
Journal of Hepatocellular Carcinoma 2023, 10:57-68
Published Date: 14 January 2023
Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients
Yang C, Wu X, Liu J, Wang H, Jiang Y, Wei Z, Cai Q
Journal of Hepatocellular Carcinoma 2023, 10:43-55
Published Date: 13 January 2023
Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma
Hamm CA, Busch F, Pöhlmann A, Shewarega A, He Y, Schmidt R, Xu H, Wieners G, Gebauer B, Savic LJ
Journal of Hepatocellular Carcinoma 2023, 10:27-42
Published Date: 12 January 2023
Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
Yu CY, Huang PH, Tsang LLC, Hsu HW, Lim WX, Weng CC, Huang TL, Hsu CC, Chen CL, Ou HY, Cheng YF
Journal of Hepatocellular Carcinoma 2023, 10:17-26
Published Date: 11 January 2023
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
Wang Q, Wang B, Ma X, Zhuang H, Xie Z, Tang C, Tan W, Yang L, Shang C, Chen Y
Journal of Hepatocellular Carcinoma 2023, 10:1-16
Published Date: 10 January 2023